Jackson–Weiss syndrome

Jackson–Weiss syndrome is a rare genetic disorder characterized by craniosynostosis, foot abnormalities, and other physical malformations. It is inherited in an autosomal dominant pattern and is caused by mutations in the FGFR2 gene.
Presentation[edit]
Individuals with Jackson–Weiss syndrome typically present with craniosynostosis, which is the premature fusion of certain skull bones. This leads to an abnormal head shape and can affect the development of the brain. Common cranial features include a prominent forehead and wide-set eyes (hypertelorism).
Foot abnormalities are another hallmark of Jackson–Weiss syndrome. These may include broad, short great toes and fusion of some of the bones in the feet (syndactyly). The hands are usually normal, which helps distinguish this syndrome from other similar conditions.
Genetics[edit]
Jackson–Weiss syndrome is caused by mutations in the FGFR2 (fibroblast growth factor receptor 2) gene, which plays a crucial role in the development and maintenance of bone and tissue. The condition follows an autosomal dominant inheritance pattern, meaning that only one copy of the altered gene is sufficient to cause the disorder.
Diagnosis[edit]
Diagnosis of Jackson–Weiss syndrome is based on clinical evaluation, identification of characteristic physical findings, and genetic testing to confirm mutations in the FGFR2 gene. Prenatal diagnosis is possible if the mutation is known in the family.
Management[edit]
Management of Jackson–Weiss syndrome typically involves a multidisciplinary approach. Surgical intervention may be required to correct craniosynostosis and foot abnormalities. Regular monitoring and supportive care are essential to address developmental delays and other complications.
Epidemiology[edit]
Jackson–Weiss syndrome is extremely rare, with only a few cases reported in the medical literature. The exact prevalence is unknown.
See also[edit]
References[edit]
External links[edit]
-
Further reading[edit]
| Medical Condition | |
|---|---|
| [[File:|250px|alt=|]] | |
| Synonyms | N/A |
| Pronounce | N/A |
| Field | N/A |
| Symptoms | N/A |
| Complications | N/A |
| Onset | N/A |
| Duration | N/A |
| Types | N/A |
| Causes | N/A |
| Risks | N/A |
| Diagnosis | N/A |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | N/A |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | N/A |
| Deaths | N/A |
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
